Publications by authors named "Jose-Luis Tandaipan"

Objective: To evaluate the main outcomes of disease activity and their association with other measures of activity, damage, and quality of life in patients with idiopathic inflammatory myopathy (IIM) according to time since diagnosis and positivity to antisynthetase autoantibodies (ASAs).

Methods: Cross-sectional multicenter study within the Spanish Myo-Spain registry. Cases were classified as incident (≤ 12 months since diagnosis) and prevalent.

View Article and Find Full Text PDF

Objectives: Idiopathic inflammatory myopathies (IIM) are a diverse group of muscle diseases often complicated by interstitial lung disease (ILD), which significantly impacts morbidity and mortality. Krebs von den Lungen-6 (sKL-6) has been proposed as a biomarker for ILD severity. Nailfold videocapillaroscopy (NVC) detects microvascular changes, but its diagnostic and prognostic value in IIM remains unclear.

View Article and Find Full Text PDF

: Cryoglobulinemia (CG) is marked by abnormal immunoglobulins (Ig) in serum, precipitating at temperatures below 37 °C. Current classification categorizes CG into three subtypes (types I, II, and III) based on Ig clonality. The features distinguishing patients with CG based on their etiology remain unidentified.

View Article and Find Full Text PDF

Introduction: This was an ambispective cohort study evaluating the prognostic significance of lymphocytic foci and its lymphoid composition in minor salivary gland biopsy (MSGB) for short-term disease flare and severity in Sjögren's syndrome (SS).

Methods: The inclusion criteria comprised individuals meeting the ACR/EULAR 2016 criteria who underwent MSGB with an infiltration of more than 50 lymphocytes and received clinical diagnosis between September 2017 and December 2018. Patients with inadequate biopsy samples were excluded.

View Article and Find Full Text PDF

Objective: We aimed to compare two matched populations of patients with MTCD with and without associated ILD and to identify predictive factors for ILD progression and severity.

Methods: This international multicenter retrospective study (14 tertiary hospitals), included MCTD patients who fulfilled at least one historical MCTD classification criteria. ILD was defined by the presence of typical chest high-resolution computed tomography (HRCT) abnormalities.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigated the outcomes of patients with systemic sclerosis (SSc) who contracted COVID-19 across different waves of the pandemic, highlighting a lack of data for this specific group.
  • A total of 333 SSc patients were analyzed, revealing a reduction in severe outcomes, hospitalizations, and deaths from wave 1 to waves 2 and 3.
  • The findings suggest that younger demographics, lower use of high-dose corticosteroids, and possibly improved healthcare responses contributed to better outcomes for SSc patients as the pandemic progressed.
View Article and Find Full Text PDF

Objectives: To estimate the prevalence of long-term exposure to glucocorticoids (GCs) and to identify factors associated with, and variations in prescribing practices over time and across recruiting countries.

Methods: We included patients with SSc having a visit recorded in the EUSTAR database from January 2013 onward. We analysed the prevalence and the main features of GCs users, their exposure to GCs over time, and their GCs dosages.

View Article and Find Full Text PDF
Article Synopsis
  • Juvenile idiopathic arthritis (JIA) is a major cause of disability in both children and adults, and this study aimed to identify factors influencing clinical remission and relapse based on treatment methods and JIA types.
  • A total of 206 JIA patients were analyzed, revealing that 70% achieved clinical remission at least once, with 29% maintaining remission without medication; better outcomes were noted for those on synthetic DMARDs alone, particularly associated with specific patient characteristics.
  • The study concluded that a significant portion of JIA patients can reach remission over time, with a lower relapse risk observed when dosages were reduced before stopping treatment, especially in those with persistent oligoarticular JIA.
View Article and Find Full Text PDF